200.09
price up icon2.46%   4.81
after-market Handel nachbörslich: 200.09
loading
Schlusskurs vom Vortag:
$195.28
Offen:
$197.1
24-Stunden-Volumen:
853.82K
Relative Volume:
0.72
Marktkapitalisierung:
$28.36B
Einnahmen:
$2.31B
Nettoeinkommen (Verlust:
$-208.16M
KGV:
-130.22
EPS:
-1.5366
Netto-Cashflow:
$76.11M
1W Leistung:
+1.22%
1M Leistung:
-4.42%
6M Leistung:
+15.77%
1J Leistung:
+32.38%
1-Tages-Spanne:
Value
$196.74
$201.87
1-Wochen-Bereich:
Value
$194.02
$204.34
52-Wochen-Spanne:
Value
$125.38
$256.36

Natera Inc Stock (NTRA) Company Profile

Name
Firmenname
Natera Inc
Name
Telefon
650-249-9090
Name
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Name
Mitarbeiter
6,140
Name
Twitter
@nateragenetics
Name
Nächster Verdiensttermin
2026-02-26
Name
Neueste SEC-Einreichungen
Name
NTRA's Discussions on Twitter

Compare NTRA vs TMO, DHR, IDXX, A, WAT

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
NTRA icon
NTRA
Natera Inc
200.09 27.68B 2.31B -208.16M 76.11M -1.5366
TMO icon
TMO
Thermo Fisher Scientific Inc
478.12 176.23B 44.56B 6.72B 6.29B 17.74
DHR icon
DHR
Danaher Corp
190.00 133.90B 24.57B 3.60B 5.26B 5.051
IDXX icon
IDXX
Idexx Laboratories Inc
578.51 45.96B 4.30B 1.06B 1.04B 13.08
A icon
A
Agilent Technologies Inc
112.02 31.45B 7.07B 1.29B 993.00M 4.5355
WAT icon
WAT
Waters Corp
301.81 29.33B 3.17B 642.63M 516.49M 10.77

Natera Inc Stock (NTRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-01-07 Eingeleitet Citigroup Buy
2025-12-02 Fortgesetzt Morgan Stanley Overweight
2025-10-27 Hochstufung BNP Paribas Exane Underperform → Neutral
2025-09-22 Fortgesetzt Wells Fargo Equal Weight
2025-03-13 Eingeleitet RBC Capital Mkts Outperform
2025-01-23 Eingeleitet Barclays Overweight
2024-06-03 Fortgesetzt Jefferies Buy
2024-04-08 Fortgesetzt Craig Hallum Buy
2024-02-20 Herabstufung Raymond James Strong Buy → Outperform
2023-12-29 Bestätigt BTIG Research Buy
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-11-13 Hochstufung Raymond James Outperform → Strong Buy
2023-09-28 Eingeleitet Bernstein Mkt Perform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-05 Eingeleitet UBS Buy
2023-01-18 Hochstufung Raymond James Mkt Perform → Outperform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-04-25 Eingeleitet Stephens Overweight
2022-03-08 Eingeleitet Goldman Buy
2022-01-06 Fortgesetzt Piper Sandler Overweight
2021-10-15 Fortgesetzt Cowen Outperform
2021-06-15 Eingeleitet Raymond James Mkt Perform
2021-05-25 Eingeleitet Wells Fargo Overweight
2021-01-28 Eingeleitet Truist Buy
2020-10-08 Eingeleitet BTIG Research Buy
2020-09-28 Eingeleitet Morgan Stanley Overweight
2020-09-17 Eingeleitet SVB Leerink Outperform
2020-06-10 Fortgesetzt Piper Sandler Overweight
2020-05-07 Hochstufung JP Morgan Neutral → Overweight
2018-10-05 Eingeleitet JP Morgan Neutral
2018-07-05 Bestätigt Piper Jaffray Overweight
2017-08-07 Bestätigt Morgan Stanley Overweight
2016-11-10 Bestätigt The Benchmark Company Buy
2016-05-23 Bestätigt The Benchmark Company Buy
2016-05-11 Bestätigt The Benchmark Company Buy
2016-04-19 Eingeleitet The Benchmark Company Buy
2015-09-28 Hochstufung Wedbush Neutral → Outperform
2015-08-14 Hochstufung Morgan Stanley Equal-Weight → Overweight
2015-08-04 Eingeleitet Robert W. Baird Outperform
2015-07-27 Eingeleitet Morgan Stanley Equal-Weight
2015-07-27 Eingeleitet Piper Jaffray Overweight
2015-07-27 Eingeleitet Wedbush Neutral
Alle ansehen

Natera Inc Aktie (NTRA) Neueste Nachrichten

pulisher
02:28 AM

Natera Inc (NTRA) Stock Price Up 2.86% on Mar 23 - GuruFocus

02:28 AM
pulisher
12:16 PM

Natera, Inc.(NasdaqGS: NTRA) added to FTSE All-World Index - marketscreener.com

12:16 PM
pulisher
Mar 20, 2026

Natera co-founder Jonathan Sheena sells shares worth $908,301 By Investing.com - Investing.com Canada

Mar 20, 2026
pulisher
Mar 20, 2026

Natera Inc (NTRA) Shares Gap Down to $196.73 on Mar 20 - GuruFocus

Mar 20, 2026
pulisher
Mar 20, 2026

Natera co-founder Jonathan Sheena sells shares worth $908,301 - Investing.com

Mar 20, 2026
pulisher
Mar 20, 2026

Natera (NASDAQ: NTRA) co-founder reports 4,570-share planned stock sale - Stock Titan

Mar 20, 2026
pulisher
Mar 20, 2026

Form 144 Natera For: 20 March By Investing.com - Investing.com South Africa

Mar 20, 2026
pulisher
Mar 20, 2026

Form 144 Natera For: 20 March - Investing.com

Mar 20, 2026
pulisher
Mar 20, 2026

Jonathan Sheena reports multiple share sales for NTRA (NASDAQ: NTRA) - Stock Titan

Mar 20, 2026
pulisher
Mar 20, 2026

Discipline and Rules-Based Execution in NTRA Response - Stock Traders Daily

Mar 20, 2026
pulisher
Mar 20, 2026

CIBC Private Wealth Group LLC Buys 53,086 Shares of Natera, Inc. $NTRA - MarketBeat

Mar 20, 2026
pulisher
Mar 20, 2026

Does Natera’s (NTRA) Expanded Genomics Suite Quietly Redefine Its Long-Term Competitive Moat? - simplywall.st

Mar 20, 2026
pulisher
Mar 19, 2026

Groupama Asset Managment Has $12.42 Million Stock Holdings in Natera, Inc. $NTRA - MarketBeat

Mar 19, 2026
pulisher
Mar 18, 2026

Unveiling Natera (NTRA) Q4 outlook: Wall Street estimates for key metrics - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

Jonathan Sheena files Rule 144 notice selling shares (NASDAQ: NTRA) - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

Natera, Inc. (NTRA) reports preliminary Q4 revenue - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

Faithward Advisors LLC Invests $3.52 Million in Natera, Inc. $NTRA - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

Livforsakringsbolaget Skandia Omsesidigt Buys 17,100 Shares of Natera, Inc. $NTRA - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

JP Morgan lifts Natera, Inc. (NTRA) target on Signatera momentum - MSN

Mar 18, 2026
pulisher
Mar 17, 2026

Insider Selling: Natera (NASDAQ:NTRA) Director Sells 122 Shares of Stock - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Natera director Chapman sells $23348 in shares - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Natera director Chapman sells $23348 in shares By Investing.com - Investing.com Australia

Mar 17, 2026
pulisher
Mar 17, 2026

Natera (NTRA) director sells 122 shares under 10b5-1 trading plan - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Natera Looks Compelling As Oncology Testing Momentum Keeps Building (NASDAQ:NTRA) - Seeking Alpha

Mar 17, 2026
pulisher
Mar 17, 2026

Natera named Healthcare Technology Company of the Year - The Healthcare Technology Report.

Mar 17, 2026
pulisher
Mar 17, 2026

A Look At Natera (NTRA) Valuation After New Signatera Data And Zenith Genomics Launch - Yahoo Finance

Mar 17, 2026
pulisher
Mar 17, 2026

Assessing Natera (NTRA) Valuation After New Signatera Data And Zenith Genomics Launch - simplywall.st

Mar 17, 2026
pulisher
Mar 17, 2026

Holocene Advisors LP Decreases Stock Holdings in Natera, Inc. $NTRA - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Boothbay Fund Management LLC Increases Position in Natera, Inc. $NTRA - MarketBeat

Mar 17, 2026
pulisher
Mar 16, 2026

Natera executive chairman sells $38.3 million in NTRA stock - Investing.com

Mar 16, 2026
pulisher
Mar 16, 2026

Natera executive chairman sells $38.3 million in NTRA stock By Investing.com - Investing.com South Africa

Mar 16, 2026
pulisher
Mar 16, 2026

NeoGenomics, Natera, and Amphastar Pharmaceuticals Stocks Soar—Key Information You Should Be Aware Of - Bitget

Mar 16, 2026
pulisher
Mar 16, 2026

NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - Yahoo Finance

Mar 16, 2026
pulisher
Mar 16, 2026

Natera (NTRA) chair Rabinowitz exercises options and sells 200,000 shares - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

NeoGenomics, Natera, and Amphastar Pharmaceuticals shares skyrocket, what you need to know - MSN

Mar 16, 2026
pulisher
Mar 16, 2026

Why Natera Stock Is Surging On Fresh Optimism - TipRanks

Mar 16, 2026
pulisher
Mar 16, 2026

NTRA Debuts Zenith Genomics Next-Gen Sequencing Test for Rare Diseases - Yahoo Finance

Mar 16, 2026
pulisher
Mar 16, 2026

Natera (NTRA) Highlights Promising Results for Signatera in Canc - GuruFocus

Mar 16, 2026
pulisher
Mar 16, 2026

Natera ctDNA test shows promise in anal, rectal cancer studies - Investing.com

Mar 16, 2026
pulisher
Mar 16, 2026

Natera ctDNA test shows promise in anal, rectal cancer studies By Investing.com - Investing.com India

Mar 16, 2026
pulisher
Mar 16, 2026

Fred Alger Management LLC Buys 41,303 Shares of Natera, Inc. $NTRA - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Farallon Capital Management LLC Sells 568,357 Shares of Natera, Inc. $NTRA - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Cancer DNA test ties anal and rectal tumors to relapse odds - Stock Titan

Mar 16, 2026
pulisher
Mar 15, 2026

Natera launches whole genome sequencing test for rare diseases - Investing.com Nigeria

Mar 15, 2026
pulisher
Mar 15, 2026

Coatue Management LLC Takes Position in Natera, Inc. $NTRA - MarketBeat

Mar 15, 2026
pulisher
Mar 15, 2026

Capital Impact Advisors LLC Boosts Stock Position in Natera, Inc. $NTRA - MarketBeat

Mar 15, 2026
pulisher
Mar 15, 2026

Aquatic Capital Management LLC Increases Position in Natera, Inc. $NTRA - MarketBeat

Mar 15, 2026
pulisher
Mar 14, 2026

Analysts Offer Insights on Healthcare Companies: Agilent (A), Natera (NTRA) and Nektar Therapeutics (NKTR) - The Globe and Mail

Mar 14, 2026
pulisher
Mar 14, 2026

Pinnbrook Capital Management LP Makes New $5.78 Million Investment in Natera, Inc. $NTRA - MarketBeat

Mar 14, 2026
pulisher
Mar 13, 2026

Guidance Update: Can Natera Inc keep up with sector leadersPortfolio Gains Summary & AI Based Trade Execution Alerts - baoquankhu1.vn

Mar 13, 2026
pulisher
Mar 13, 2026

[144] Natera, Inc. SEC Filing - Stock Titan

Mar 13, 2026

Finanzdaten der Natera Inc-Aktie (NTRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
IQV IQV
$166.96
price up icon 0.54%
WAT WAT
$301.81
price up icon 0.94%
MTD MTD
$1,239.07
price up icon 2.87%
A A
$112.02
price up icon 0.65%
LH LH
$264.42
price up icon 0.54%
Kapitalisierung:     |  Volumen (24h):